{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T00:34:18Z","timestamp":1760402058367,"version":"build-2065373602"},"reference-count":62,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2022,1,13]],"date-time":"2022-01-13T00:00:00Z","timestamp":1642032000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007751","name":"AGH University of Science and Technology","doi-asserted-by":"publisher","award":["Dzia\u0142anie 4 w Projekcie \u201eInicjatywa Doskona\u0142o\u015bci \u2013 Uczelnia Badawcza\u201d w AGH"],"award-info":[{"award-number":["Dzia\u0142anie 4 w Projekcie \u201eInicjatywa Doskona\u0142o\u015bci \u2013 Uczelnia Badawcza\u201d w AGH"]}],"id":[{"id":"10.13039\/501100007751","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccines"],"abstract":"<jats:p>The paper is devoted to optimal vaccination scheduling during a pandemic to minimize the probability of infection. The recent COVID-19 pandemic showed that the international community is not properly prepared to manage a crisis of this scale. Just after the vaccines had been approved by medical agencies, the policymakers needed to decide on the distribution strategy. To successfully fight the pandemic, the key is to find the equilibrium between the vaccine distribution schedule and the available supplies caused by limited production capacity. This is why society needs to be divided into stratified groups whose access to vaccines is prioritized. Herein, we present the problem of distributing protective actions (i.e., vaccines) and formulate two mixed-integer programs to solve it. The problem of distributing protective actions (PDPA) aims at finding an optimal schedule for a given set of social groups with a constant probability of infection. The problem of distributing protective actions with a herd immunity threshold (PDPAHIT) also includes a variable probability of infection, i.e., the situation when herd immunity is obtained. The results of computational experiments are reported and the potential of the models is illustrated with examples.<\/jats:p>","DOI":"10.3390\/vaccines10010116","type":"journal-article","created":{"date-parts":[[2022,1,14]],"date-time":"2022-01-14T03:14:56Z","timestamp":1642130096000},"page":"116","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Vaccination Schedule under Conditions of Limited Vaccine Production Rate"],"prefix":"10.3390","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9156-6995","authenticated-orcid":false,"given":"Roger","family":"Ksi\u0105\u017cek","sequence":"first","affiliation":[{"name":"Faculty of Management, AGH University of Science and Technology, 30-059 Cracow, Poland"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1596-9749","authenticated-orcid":false,"given":"Rados\u0142aw","family":"Kap\u0142an","sequence":"additional","affiliation":[{"name":"Faculty of Management, AGH University of Science and Technology, 30-059 Cracow, Poland"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7964-3724","authenticated-orcid":false,"given":"Katarzyna","family":"Gdowska","sequence":"additional","affiliation":[{"name":"Faculty of Management, AGH University of Science and Technology, 30-059 Cracow, Poland"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5203-4099","authenticated-orcid":false,"given":"Piotr","family":"\u0141ebkowski","sequence":"additional","affiliation":[{"name":"Faculty of Management, AGH University of Science and Technology, 30-059 Cracow, Poland"}]}],"member":"1968","published-online":{"date-parts":[[2022,1,13]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1136\/medethics-2020-106850","article-title":"Ethical allocation of future COVID-19 vaccines","volume":"47","author":"Gupta","year":"2021","journal-title":"J. Med. Ethics"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1080\/03007995.2021.1908245","article-title":"Considerations for fair prioritization of COVID-19 vaccine and its mandate among healthcare personnel","volume":"37","author":"Hughes","year":"2021","journal-title":"Curr. Med. Res. Opin."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1080\/21645515.2020.1827882","article-title":"Who should be prioritised for COVID-19 vaccination?","volume":"17","author":"Russell","year":"2021","journal-title":"Hum. Vaccines Immunother."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Bolcato, M., Rodriguez, D., Feola, A., Mizio, G.D., Bonsignore, A., Ciliberti, R., Tettamanti, C., Aurilio, M.T., and Aprile, A. (2021). COVID-19 Pandemic and Equal Access to Vaccines. Vaccines, 9.","DOI":"10.3390\/vaccines9060538"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Yang, J., Zheng, W., Shi, H., Yan, X., Dong, K., You, Q., Zhong, G., Gong, H., Chen, Z., and Jit, M. (2021). Who should be prioritized for COVID-19 vaccination in China? A descriptive study. BMC Med., 19.","DOI":"10.1186\/s12916-021-01923-8"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"210429","DOI":"10.1098\/rsos.210429","article-title":"Optimal governance and implementation of vaccination programmes to contain the COVID-19 pandemic","volume":"8","author":"Piraveenan","year":"2021","journal-title":"R. Soc. Open Sci."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Savoia, E., Piltch-Loeb, R., Goldberg, B., Miller-Idriss, C., Hughes, B., Montrond, A., Kayyem, J., and Testa, M.A. (2021). Predictors of COVID-19 Vaccine Hesitancy: Socio-Demographics, Co-Morbidity, and Past Experience of Racial Discrimination. Vaccines, 9.","DOI":"10.1101\/2021.01.12.21249152"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Wang, J., Jing, R., Lai, X., Zhang, H., Lyu, Y., Knoll, M.D., and Fang, H. (2020). Acceptance of covid-19 vaccination during the covid-19 pandemic in china. Vaccines, 8.","DOI":"10.3390\/vaccines8030482"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Sattar, N.S., and Arifuzzaman, S. (2021). COVID-19 Vaccination Awareness and Aftermath: Public Sentiment Analysis on Twitter Data and Vaccinated Population Prediction in the USA. Appl. Sci., 11.","DOI":"10.3390\/app11136128"},{"key":"ref_10","unstructured":"Centers for Desease Control and Prevention (2021, December 10). Different COVID-19 Vaccines, Available online: https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/vaccines\/different-vaccines.html."},{"key":"ref_11","unstructured":"European Medcines Agency (2021, December 10). Human Medicine European Public Assessment Report (EPAR): COVID-19 Vaccine Janssen (Updated). Available online: https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/covid-19-vaccine-janssen."},{"key":"ref_12","unstructured":"European Medicines Agency (2021, December 10). Human Medicine European Public Assessment Report (EPAR): Comirnaty (Updated). Technical Report, Brussels. Available online: https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/comirnaty."},{"key":"ref_13","unstructured":"European Medicines Agency (2021, December 10). Human Medicine European Public Assessment Report (EPAR): Spikevax (Previously COVID-19 Vaccine Moderna) (Updated). Technical Report, Brussels. Available online: https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/vaxzevria-previously-covid-19-vaccine-astrazeneca."},{"key":"ref_14","unstructured":"European Medicines Agency (2021, December 10). Human Medicine European Public Assessment Report (EPAR): Vaxzevria (Previously COVID-19 Vaccine AstraZeneca) (Updated). Technical Report, Brussels. Available online: https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/spikevax."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1002\/eji.202048663","article-title":"COVID-19 vaccines: Knowing the unknown","volume":"50","author":"Lv","year":"2020","journal-title":"Eur. J. Immunol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"110621","DOI":"10.1016\/j.jtbi.2021.110621","article-title":"Estimating the reproductive number R0 of SARS-CoV-2 in the United States and eight European countries and implications for vaccination","volume":"517","author":"Ke","year":"2021","journal-title":"J. Theor. Biol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.idnow.2021.03.001","article-title":"Mosaic vaccination schedule: An unexpected card to play against SARS-CoV-2?","volume":"51","author":"Ricco","year":"2021","journal-title":"Infect. Dis. Now"},{"key":"ref_18","unstructured":"Alleman, T., Torfs, E., and Nopens, I. (2021, December 10). Covid-19: From Model Prediction to Model Predictive. Available online: https:\/\/biomath.ugent.be\/sites\/default\/files\/2020-04\/Alleman_etal_v2.pdf."},{"key":"ref_19","first-page":"254","article-title":"Herd immunity, vaccine development and BCG effects in COVID-19","volume":"31","author":"Ko","year":"2020","journal-title":"J. Intern. Med. Taiwan"},{"key":"ref_20","unstructured":"World Health Organization (2020). Prioritized Infectious Disease and Economic Modeling Questions, World Health Organization. Technical Report."},{"key":"ref_21","unstructured":"Toner, E., Barnill, A., Krubiner, C., Bernstein, J., Watson, M., Martin, E., Potter, C., Hosangadi, D., Connell, N., and Watson, C. (2020). Interim Framework for COVID-19 Vaccine Allocation and Distribution in the United States, The Johns Hopkins Center for Health Security. Available online: https:\/\/www.centerforhealthsecurity.org\/our-work\/publications\/interim-framework-for-covid-19-vaccine-allocation-and-distribution-in-the-us."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"m4750","DOI":"10.1136\/bmj.m4750","article-title":"Reserving coronavirus disease 2019 vaccines for global access: Cross sectional analysis","volume":"371","author":"So","year":"2020","journal-title":"BMJ"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Siedner, M.J., Alba, C., Fitzmaurice, K.P., Gilbert, R.F., Scott, J.A., Shebl, F.M., Ciaranello, A., Reddy, K.P., and Freedberg, K.A. (2021). Cost-effectiveness of COVID-19 vaccination in low- and middle-income countries. medRxiv.","DOI":"10.1101\/2021.04.28.21256237"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"108614","DOI":"10.1016\/j.mbs.2021.108614","article-title":"COVID-19 optimal vaccination policies: A modeling study on efficacy, natural and vaccine-induced immunity responses","volume":"337","year":"2021","journal-title":"Math. Biosci."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Makhoul, M., Ayoub, H.H., Chemaitelly, H., Seedat, S., Mumtaz, G.R., Al-Omari, S., and Abu-Raddad, L.J. (2020). Epidemiological Impact of SARS-CoV-2 Vaccination: Mathematical Modeling Analyses. Vaccines, 8.","DOI":"10.1101\/2020.04.19.20070805"},{"key":"ref_26","first-page":"148","article-title":"A primer on using mathematics to understand COVID-19 dynamics: Modeling, analysis and simulations","volume":"6","author":"Gumel","year":"2021","journal-title":"Infect. Dis. Model."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Fuady, A., Nuraini, N., Sukandar, K.K., and Lestari, B.W. (2021). Targeted vaccine allocation could increase the covid-19 vaccine benefits amidst its lack of availability: A mathematical modeling study in indonesia. Vaccines, 9.","DOI":"10.3390\/vaccines9050462"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s12976-021-00143-0","article-title":"Modelling the impact of delaying vaccination against SARS-CoV-2 assuming unlimited vaccine supply","volume":"18","author":"Amaku","year":"2021","journal-title":"Theor. Biol. Med. Model."},{"key":"ref_29","first-page":"510","article-title":"Will an imperfect vaccine curtail the COVID-19 pandemic in the U.S.?","volume":"5","author":"Iboi","year":"2020","journal-title":"Infect. Dis. Model."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"2020-12","DOI":"10.3389\/fpubh.2021.709369","article-title":"Toward Achieving a Vaccine-Derived Herd Immunity Threshold for COVID-19 in the U.S","volume":"9","author":"Gumel","year":"2021","journal-title":"Front. Public Health"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1126\/science.abe6959","article-title":"Model-informed COVID-19 vaccine prioritization strategies by age and serostatus","volume":"371","author":"Bubar","year":"2021","journal-title":"Science"},{"key":"ref_32","first-page":"751","article-title":"Multi-generational SIR modeling: Determination of parameters, epidemiological forecasting and age-dependent vaccination policies","volume":"6","author":"Campos","year":"2021","journal-title":"Infect. Dis. Model."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.ijid.2020.12.075","article-title":"Comparing COVID-19 vaccine allocation strategies in India: A mathematical modelling study","volume":"103","author":"Foy","year":"2021","journal-title":"Int. J. Infect. Dis."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s40484-020-0199-0","article-title":"Modeling the epidemic dynamics and control of COVID-19 outbreak in China","volume":"8","author":"Zhao","year":"2020","journal-title":"Quant. Biol."},{"key":"ref_35","first-page":"98","article-title":"Modeling and forecasting of COVID-19 using a hybrid dynamic model based on SEIRD with ARIMA corrections","volume":"6","author":"Majdalawieh","year":"2021","journal-title":"Infect. Dis. Model."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"110057","DOI":"10.1016\/j.chaos.2020.110057","article-title":"A SIR model assumption for the spread of COVID-19 in different communities","volume":"139","author":"Cooper","year":"2020","journal-title":"Chaos Solitons Fractals"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S0140-6736(20)30260-9","article-title":"Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: A modelling study","volume":"395","author":"Wu","year":"2020","journal-title":"Lancet"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/S1473-3099(20)30144-4","article-title":"Early dynamics of transmission and control of COVID-19: A mathematical modelling study","volume":"20","author":"Kucharski","year":"2020","journal-title":"Lancet Infect. Dis."},{"key":"ref_39","first-page":"eabj2099","article-title":"Geographically-targeted COVID-19 vaccination is more equitable than age-based thresholds alone","volume":"20","author":"Kiang","year":"2021","journal-title":"Sci. Adv."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Chen, X., Li, M., Simchi-Levi, D., and Zhao, T. (2020). Allocation of COVID-19 Vaccines Under Limited Supply. SSRN Electron. J.","DOI":"10.2139\/ssrn.3678986"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1002\/ajim.23220","article-title":"Commercial truck drivers should be a priority population for COVID-19 vaccinations","volume":"64","author":"Lemke","year":"2021","journal-title":"Am. J. Ind. Med."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Yu, H., Han, S., Cai, J., Yang, J., Zhang, J., Wu, Q., Zheng, W., Shi, H., Ajelli, M., and Zhou, X. Dynamic optimization of COVID-19 vaccine prioritization in the context of limited supply. Res. Sq. Nat. Portf., 2021.","DOI":"10.21203\/rs.3.rs-257573\/v1"},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"MacIntyre, C.R., Costantino, V., and Trent, M. (2021). Modelling of COVID-19 vaccination strategies and herd immunity, in scenarios of limited and full vaccine supply in NSW, Australia. Vaccine, in press.","DOI":"10.1101\/2020.12.15.20248278"},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Shim, E. (2021). Optimal Allocation of the Limited COVID-19 Vaccine Supply in South Korea. J. Clin. Med., 10.","DOI":"10.3390\/jcm10040591"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"278","DOI":"10.2174\/1874434602014010278","article-title":"Vaccination Schedules and COVID-19 Risk","volume":"14","author":"Allam","year":"2020","journal-title":"Open Microbiol. J."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1093\/ajhp\/zxab184","article-title":"Strategies used to meet the challenges of mass COVID-19 vaccination by the pharmacy department in a large academic medical center","volume":"78","author":"Li","year":"2021","journal-title":"Am. J. Health-Syst. Pharm."},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Hanly, M., Churches, T., Fitzgerald, O., Caterson, I., MacIntyre, C.R., and Jorm, L. (2021). Modelling vaccination capacity at mass vaccination hubs and general practice clinics. medRxiv.","DOI":"10.1101\/2021.04.07.21255067"},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"(2020). More attacks on Covid-19 vaccine suppliers and supply chain. Comput. Fraud. Secur., 2020, 1\u20133.","DOI":"10.1016\/S1361-3723(20)30122-6"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"5418","DOI":"10.1016\/j.vaccine.2020.06.022","article-title":"Emerging manufacturers engagements in the COVID-19 vaccine research, development and supply","volume":"38","author":"Pagliusi","year":"2020","journal-title":"Vaccine"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1109\/OJCS.2021.3067450","article-title":"Blockchain Platform For COVID-19 Vaccine Supply Management","volume":"2","author":"Antal","year":"2021","journal-title":"IEEE Open J. Comput. Soc."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s13662-020-03173-z","article-title":"Complexity analysis of cold chain transportation in a vaccine supply chain considering activity inspection and time-delay","volume":"2021","author":"Dai","year":"2021","journal-title":"Adv. Differ. Equ."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"8318","DOI":"10.1016\/j.vaccine.2020.11.011","article-title":"The role of manufacturers in the implementation of global traceability standards in the supply chain to combat vaccine counterfeiting and enhance safety monitoring","volume":"38","author":"Jarrett","year":"2020","journal-title":"Vaccine"},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Golan, M.S., Trump, B.D., Cegan, J.C., and Linkov, I. (2021). The Vaccine Supply Chain: A Call for Resilience Analytics to Support COVID-19 Vaccine Production and Distribution. COVID-19: Systemic Risk and Resilience, Springer.","DOI":"10.1007\/978-3-030-71587-8_22"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1038\/d41586-021-00340-4","article-title":"Variant-proof vaccines\u2014Invest now for the next pandemic","volume":"590","author":"Burton","year":"2021","journal-title":"Nature"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.mbs.2013.04.013","article-title":"The scaling of contact rates with population density for the infectious disease models","volume":"244","author":"Hu","year":"2013","journal-title":"Math. Biosci."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/s40808-020-00984-7","article-title":"Impact of population density on Covid-19 infected and mortality rate in India","volume":"7","author":"Bhadra","year":"2021","journal-title":"Model. Earth Syst. Environ."},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Moghadas, S.M., Vilches, T.N., Zhang, K., Nourbakhsh, S., Sah, P., Fitzpatrick, M.C., and Galvani, A.P. (2021). Evaluation of COVID-19 vaccination strategies with a delayed second dose. PLoS Biol., 19.","DOI":"10.1101\/2021.01.27.21250619"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"2360","DOI":"10.1016\/j.vaccine.2021.03.058","article-title":"Projecting the impact of a two-dose COVID-19 vaccination campaign in Ontario, Canada","volume":"39","author":"Vilches","year":"2021","journal-title":"Vaccine"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/BF01589344","article-title":"Integer programming duality: Price functions and sensitivity analysis","volume":"20","author":"Wolsey","year":"1981","journal-title":"Math. Program."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1287\/opre.33.5.1008","article-title":"Sensitivity analysis for branch and bound integer programming","volume":"33","author":"Schrage","year":"1985","journal-title":"Oper. Res."},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Roos, C. (2003). Linear Optimization. Encyclopedia of Physical Science and Technology, Elsevier.","DOI":"10.1016\/B0-12-227410-5\/00379-3"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"106421","DOI":"10.1016\/j.ypmed.2021.106421","article-title":"Looking to the empirical literature on the potential for financial incentives to enhance adherence with COVID-19 vaccination","volume":"145","author":"Higgins","year":"2021","journal-title":"Prev. Med."}],"container-title":["Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-393X\/10\/1\/116\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T13:27:13Z","timestamp":1760362033000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-393X\/10\/1\/116"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,13]]},"references-count":62,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,1]]}},"alternative-id":["vaccines10010116"],"URL":"https:\/\/doi.org\/10.3390\/vaccines10010116","relation":{},"ISSN":["2076-393X"],"issn-type":[{"type":"electronic","value":"2076-393X"}],"subject":[],"published":{"date-parts":[[2022,1,13]]}}}